Literature DB >> 16857782

Selective TRAIL-induced apoptosis in dysplastic neoplasia of the colon may lead to new neoadjuvant or adjuvant therapies.

Niklas Finnberg1, Wafik S El-Deiry.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16857782     DOI： 10.1158/1078-0432.CCR-06-0567

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN： 1078-0432            Impact factor:   12.531


× No keyword cloud information.
  4 in total

1.  TRAIL-R4 promotes tumor growth and resistance to apoptosis in cervical carcinoma HeLa cells through AKT.

Authors:  Najoua Lalaoui; Aymeric Morlé; Delphine Mérino; Guillaume Jacquemin; Elisabetta Iessi; Alexandre Morizot; Sarah Shirley; Bruno Robert; Eric Solary; Carmen Garrido; Olivier Micheau
Journal:  PLoS One       Date:  2011-05-20       Impact factor: 3.240

Review 2.  Oncoapoptotic markers in oral cancer: prognostics and therapeutic perspective.

Authors:  Anubhav Jain; Saurabh Bundela; Ram P Tiwari; Prakash S Bisen
Journal:  Mol Diagn Ther       Date:  2014-10       Impact factor: 4.074

3.  Reduction of decoy receptor 3 enhances TRAIL-mediated apoptosis in pancreatic cancer.

Authors:  Wei Wang; Mei Zhang; Weimin Sun; Shanmin Yang; Ying Su; Hengshan Zhang; Chaomei Liu; Xinfeng Li; Ling Lin; Sunghee Kim; Paul Okunieff; Zhenhuan Zhang; Lurong Zhang
Journal:  PLoS One       Date:  2013-10-25       Impact factor: 3.240

4.  Repression of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) but not its receptors during oral cancer progression.

Authors:  Nadarajah Vigneswaran; Darryl C Baucum; Jean Wu; Yahuan Lou; Jerry Bouquot; Susan Muller; Wolfgang Zacharias
Journal:  BMC Cancer       Date:  2007-06-25       Impact factor: 4.430
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.